21 May 2020
Bladder cancer is associated with significant illness and mortality, particularly if treatment is delayed. Writing in the journal Bladder Cancer, researchers have outlined recommendations for treatment of both muscle invasive and non-muscle invasive bladder cancer during the COVID-19 pandemic based on data from trials and prior studies, and taking into account the current strains on the healthcare system.
23 September 2019
15 May 2019
We are pleased to welcome Bishoy Faltas, MD as the new social media edtior for Bladder Cancer! Dr Faltas is a physician-scientist at Weill Cornell Medicine, New York, USA.
31 October 2018
Rochester, NY, USA – Leading researchers and clinicians from across the globe gathered in Rochester on October 18–19 to recognize the career of Edward Messing, MD, FACS, and his 35 years of accomplishments in improving care for individuals with bladder, kidney, prostate, and testicular cancer. The Festschrift honoring Messing, a professor in the University of Rochester Medical Center (URMC) Department of Urology and the Wilmot Cancer Institute, was the subject of a special edition of the journal Bladder Cancer.
24 May 2018
Top Cancer Clinician-Scientist Appointed Director of Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai
16 January 2018
Amsterdam, NL and Bethesda, US – IOS Press, an international scientific, technical and medical publisher, and the Bladder Cancer Advocacy Network (BCAN), are pleased to announce that the journal Bladder Cancer is now the official journal of BCAN.
16 February 2017
Bladder Cancer (BLC) is proud to announce the launch of the Bladder Cancer Funding Analyzer (BCFA) on the BLC website. It is a free service that is part of a new suite of online features that have been designed to serve the needs of the bladder cancer research community.
22 February 2016
19 February 2016
The ability to map the human genome has transformed how scientists and researchers classify various cancers. In the past, cancer cells were examined through a microscope and their appearance, often enhanced with dyes or other agents, was used to categorize the type of cancer.